Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schenker, H. M. (VerfasserIn), Tascilar, K. (VerfasserIn), Konerth, L. (VerfasserIn), Sergeeva, M. (VerfasserIn), Prade, J. (VerfasserIn), Strobelt, S. (VerfasserIn), Kleyer, A. (VerfasserIn), Simon, D. (VerfasserIn), Mendez, L. (VerfasserIn), Hagen, M. (VerfasserIn), Schönau, V. (VerfasserIn), Hueber, A. (VerfasserIn), Roesch, J. (VerfasserIn), Dörfler, A. (VerfasserIn), Hess, A. (VerfasserIn), Schett, G. (VerfasserIn), Rech, J. (VerfasserIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2021
Schlagworte:
Online-Zugang:kostenfrei
kostenfrei
kostenfrei
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nmm a2200000zc 4500
001 BV048388854
003 DE-604
005 00000000000000.0
007 cr|uuu---uuuuu
008 220803s2021 gw |||| o||u| ||||||eng d
015 |a 22,O06  |2 dnb 
016 7 |a 1258525682  |2 DE-101 
024 7 |a urn:nbn:de:bvb:29-opus4-194092  |2 urn 
035 |a (OCoLC)1339064718 
035 |a (DE-599)DNB1258525682 
040 |a DE-604  |b ger  |e rda 
041 0 |8 3\p  |a eng 
044 |a gw  |c XA-DE-BY 
049 |a DE-29 
084 |8 1\p  |a 615.5  |2 23ksdnb 
084 |8 2\p  |a 610  |2 23sdnb 
100 1 |a Schenker, H. M.  |e Verfasser  |4 aut 
245 1 0 |a Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study  |c H. M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech 
264 1 |a Erlangen ; Nürnberg  |b Friedrich-Alexander-Universität Erlangen-Nürnberg  |c 2021 
300 |a 1 Online-Ressource 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
338 |b cr  |2 rdacarrier 
583 1 |a Archivierung/Langzeitarchivierung gewährleistet  |5 DE-101  |2 pdager 
653 |a Rheumatoid arthritis 
653 |a functional MRI 
653 |a TNF inhibition 
653 |a Neuroimaging 
700 1 |a Tascilar, K.  |e Verfasser  |4 aut 
700 1 |a Konerth, L.  |e Verfasser  |4 aut 
700 1 |a Sergeeva, M.  |e Verfasser  |4 aut 
700 1 |a Prade, J.  |e Verfasser  |4 aut 
700 1 |a Strobelt, S.  |e Verfasser  |4 aut 
700 1 |a Kleyer, A.  |e Verfasser  |4 aut 
700 1 |a Simon, D.  |e Verfasser  |4 aut 
700 1 |a Mendez, L.  |e Verfasser  |4 aut 
700 1 |a Hagen, M.  |e Verfasser  |4 aut 
700 1 |a Schönau, V.  |e Verfasser  |4 aut 
700 1 |a Hueber, A.  |e Verfasser  |4 aut 
700 1 |a Roesch, J.  |e Verfasser  |4 aut 
700 1 |a Dörfler, A.  |e Verfasser  |4 aut 
700 1 |a Hess, A.  |e Verfasser  |4 aut 
700 1 |a Schett, G.  |e Verfasser  |4 aut 
700 1 |a Rech, J.  |e Verfasser  |4 aut 
787 0 8 |i Sonderdruck aus  |t Contemporary Clinical Trials Communications  |g Vol. 22 (2021)  |o 10.1016/j.conctc.2021.100770 
856 4 0 |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-194092  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://d-nb.info/1258525682/34  |x Langzeitarchivierung Nationalbibliothek  |z kostenfrei  |3 Volltext 
856 4 0 |q application/pdf  |u https://open.fau.de/handle/openfau/19409  |x Verlag  |z kostenfrei  |3 Volltext 
912 |a ebook 
999 |a oai:aleph.bib-bvb.de:BVB01-033767605 
883 0 |8 1\p  |a emakn  |c 0,03479  |d 20220528  |q DE-101  |u https://d-nb.info/provenance/plan#emakn 
883 0 |8 2\p  |a aepsg  |c 0,97936  |d 20220528  |q DE-101  |u https://d-nb.info/provenance/plan#aepsg 
883 1 |8 3\p  |a npi  |d 20220527  |q DE-101  |u https://d-nb.info/provenance/plan#npi 

Datensatz im Suchindex

_version_ 1804184275164069888
adam_txt
any_adam_object
any_adam_object_boolean
author Schenker, H. M.
Tascilar, K.
Konerth, L.
Sergeeva, M.
Prade, J.
Strobelt, S.
Kleyer, A.
Simon, D.
Mendez, L.
Hagen, M.
Schönau, V.
Hueber, A.
Roesch, J.
Dörfler, A.
Hess, A.
Schett, G.
Rech, J.
author_facet Schenker, H. M.
Tascilar, K.
Konerth, L.
Sergeeva, M.
Prade, J.
Strobelt, S.
Kleyer, A.
Simon, D.
Mendez, L.
Hagen, M.
Schönau, V.
Hueber, A.
Roesch, J.
Dörfler, A.
Hess, A.
Schett, G.
Rech, J.
author_role aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
aut
author_sort Schenker, H. M.
author_variant h m s hm hms
k t kt
l k lk
m s ms
j p jp
s s ss
a k ak
d s ds
l m lm
m h mh
v s vs
a h ah
j r jr
a d ad
a h ah
g s gs
j r jr
building Verbundindex
bvnumber BV048388854
collection ebook
ctrlnum (OCoLC)1339064718
(DE-599)DNB1258525682
format Electronic
eBook
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02901nmm a2200661zc 4500</leader><controlfield tag="001">BV048388854</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220803s2021 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,O06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1258525682</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-194092</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1339064718</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1258525682</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">615.5</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schenker, H. M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study</subfield><subfield code="c">H. M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rheumatoid arthritis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">functional MRI</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TNF inhibition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neuroimaging</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tascilar, K.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Konerth, L.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sergeeva, M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prade, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Strobelt, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kleyer, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simon, D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mendez, L.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hagen, M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schönau, V.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hueber, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roesch, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dörfler, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hess, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schett, G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rech, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Contemporary Clinical Trials Communications</subfield><subfield code="g">Vol. 22 (2021)</subfield><subfield code="o">10.1016/j.conctc.2021.100770</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-194092</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://d-nb.info/1258525682/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="q">application/pdf</subfield><subfield code="u">https://open.fau.de/handle/openfau/19409</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033767605</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,03479</subfield><subfield code="d">20220528</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepsg</subfield><subfield code="c">0,97936</subfield><subfield code="d">20220528</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepsg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20220527</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield></record></collection>
id DE-604.BV048388854
illustrated Not Illustrated
index_date 2024-07-03T20:20:28Z
indexdate 2024-07-10T09:36:45Z
institution BVB
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-033767605
oclc_num 1339064718
open_access_boolean 1
owner DE-29
owner_facet DE-29
physical 1 Online-Ressource
psigel ebook
publishDate 2021
publishDateSearch 2021
publishDateSort 2021
publisher Friedrich-Alexander-Universität Erlangen-Nürnberg
record_format marc
spelling Schenker, H. M. Verfasser aut
Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study H. M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech
Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2021
1 Online-Ressource
txt rdacontent
c rdamedia
cr rdacarrier
Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager
Rheumatoid arthritis
functional MRI
TNF inhibition
Neuroimaging
Tascilar, K. Verfasser aut
Konerth, L. Verfasser aut
Sergeeva, M. Verfasser aut
Prade, J. Verfasser aut
Strobelt, S. Verfasser aut
Kleyer, A. Verfasser aut
Simon, D. Verfasser aut
Mendez, L. Verfasser aut
Hagen, M. Verfasser aut
Schönau, V. Verfasser aut
Hueber, A. Verfasser aut
Roesch, J. Verfasser aut
Dörfler, A. Verfasser aut
Hess, A. Verfasser aut
Schett, G. Verfasser aut
Rech, J. Verfasser aut
Sonderdruck aus Contemporary Clinical Trials Communications Vol. 22 (2021) 10.1016/j.conctc.2021.100770
https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-194092 Resolving-System kostenfrei Volltext
https://d-nb.info/1258525682/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext
application/pdf https://open.fau.de/handle/openfau/19409 Verlag kostenfrei Volltext
1\p emakn 0,03479 20220528 DE-101 https://d-nb.info/provenance/plan#emakn
2\p aepsg 0,97936 20220528 DE-101 https://d-nb.info/provenance/plan#aepsg
3\p npi 20220527 DE-101 https://d-nb.info/provenance/plan#npi
spellingShingle Schenker, H. M.
Tascilar, K.
Konerth, L.
Sergeeva, M.
Prade, J.
Strobelt, S.
Kleyer, A.
Simon, D.
Mendez, L.
Hagen, M.
Schönau, V.
Hueber, A.
Roesch, J.
Dörfler, A.
Hess, A.
Schett, G.
Rech, J.
Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study
title Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study
title_auth Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study
title_exact_search Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study
title_exact_search_txtP Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study
title_full Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study H. M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech
title_fullStr Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study H. M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech
title_full_unstemmed Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study H. M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech
title_short Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study
title_sort prediction of response to certolizumab pegol in rheumatoid arthritis precepra by functional mri of the brain study protocol for a randomized double blind controlled study
url https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-194092
https://d-nb.info/1258525682/34
https://open.fau.de/handle/openfau/19409
work_keys_str_mv AT schenkerhm predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT tascilark predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT konerthl predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT sergeevam predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT pradej predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT strobelts predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT kleyera predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT simond predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT mendezl predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT hagenm predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT schonauv predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT huebera predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT roeschj predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT dorflera predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT hessa predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT schettg predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy
AT rechj predictionofresponsetocertolizumabpegolinrheumatoidarthritispreceprabyfunctionalmriofthebrainstudyprotocolforarandomizeddoubleblindcontrolledstudy